Mycelx Di Regulatory News (MYX)

11 April 2024

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

EPA Publishes National Drinking Water Standards

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company transforming the environmental impact of industry, notes the announcement by the United States Environmental Protection Agency ("EPA") regarding the first-ever national, legally enforceable drinking water standards for PFAS exposure.

MYCELX notes that the EPA has announced the first-ever national, legally enforceable drinking water standard to protect communities from exposure to harmful PFAS substances known as "forever chemicals". PFAS exposure has been linked to several cancers, liver and heart issues, and immune and developmental damage to infants and children. The final rule will reduce PFAS exposure for approximately 100 million people, preventing deaths and reducing serious illnesses. There will be circa $1 billion in newly available funding through the Bipartisan Infrastructure Law to help states and territories implement PFAS testing and treatment at public water systems and to help owners of private wells address PFAS contamination in addition to a $9 billion investment to help communities with drinking water impacted by PFAS and other emerging contaminants.

More details can be found at the following link: https://www.epa.gov/newsreleases/biden-harris-administration-finalizes-first-ever-national-drinking-water-standard

Connie Mixon, CEO, commented:

"We are very pleased to see this announcement by the EPA. The need for successful treatment of "forever chemicals" is now acknowledged and funding is being made available which will accelerate the adoption of new and more effective technology such as ours. MYCELX is engaged and very focused on the PFAS remediation market, as the Company's unique and patented technology is proven to successfully treat water and remediate sites that have been contaminated by PFAS chemicals, up to current EPA water standards."

For further information, please contact: